요검사 시장, 점유율, 시장 규모, 동향, 산업 분석 보고서, 제품별, 용도별, 지역별, 부문별 예측(2023-2032년)

The size of the global urinalysis market was estimated at USD 4.00 billion in 2022 and is anticipated to increase at a CAGR of 7.19% from 2023 to 2032.The report "Urinalysis Market Share, Size, Trends, Industry Analysis Report, By Product (Instrument, Consumables); By Application; By Region; Segment Forecast, 2022-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market for urine testing is growing as a result of factors like the rising incidence of conditions like diabetes, kidney illness, and urinary tract infections (UTIs). The expanded use of sophisticated and automated The National Diabetes Statistical Report, 2020 estimates that 34.2 million adults in the United States have diabetes. Around one-third of those with diabetes also have kidney-related comorbidities because of high blood sugar and blood pressure.

The market for urinalysis was mostly unaffected by the early COVID-19 pandemic due to the low hospitalization rate and declining sales of urine analysis tests. Less people had access to diagnostic and medical services as a result of the government-imposed statewide curfews, which reduced demand for diagnostics products.

An increase in approvals and the release of novel urinalysis instruments are expected to stimulate market growth. For instance, in January 2022, Bio-Rad Laboratories, Inc. introduced the Quantification Advanced Control technology to track the precision urinalysis test method in clinical labs. This equipment increased the efficiency of the laboratory's statistical process control and future product demand.

The rising importance of urinalysis in the diagnosis of post-COVID-19 diseases, particularly acute kidney & tubular injuries, is expected to fuel market expansion. The kidney injury marker-1 (KIM-1) and urinary NGAL were revealed to be two sensitive biomarkers for identifying patients with tubular and renal injury by the Columbia University study (2021).

Urinalysis Market Report Highlights

The urinary tract infection segment dominated the market in 2022 due to the rising prevalence of UTIs around the world. Urinary tract infections are thought to affect 150 million individuals annually worldwide, according to the National Library of Medicine.

A critical screening method to find diabetes is a urinalysis. By 2022, the CDC predicts that 37.3 million Americans will have diabetes. While 8.5 million people go undiagnosed, around 28.7 million people get a diagnosis. As a result, the market is driven by the rising number of diabetes patients.

North America dominated the market in 2022, accounting for major shares. Its domination may be the result of deliberate decisions made by key players, such as licencing agreements to expand their footprint. For instance, Sysmex and Siemens Healthcare GmbH entered into an exclusive licencing agreement in 2020 to provide hospital and reference laboratories in North America with the automated urine analyzer CLINITEK Novus and support it. This transaction will increase the market.

Abbott, Sysmex Corporation, ACON Laboratories, ARKRAY Inc., and Quindel Corporation are a few of the prominent competitors in the international market.

Polaris Market Research has segmented the Urinalysis Market report based on product, application, and region:

Urinalysis Market, Product Outlook (Revenue - USD Billion, 2018 - 2030)

• Instrument
• Consumables

Urinalysis Market, Application Outlook (Revenue - USD Billion, 2018 - 2030)

• Disease Screening.
• Fertility and Pregnancy Testing

Urinalysis Market, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Urinalysis Market Insights

• 4.1. Urinalysis Market - Industry Snapshot
• 4.2. Urinalysis Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing prevalence of target diseases
    • 4.2.1.2. Growing base of geriatric population
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Lack of healthcare infrastructure
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTLE Analysis
• 4.5. Urinalysis Industry trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Urinalysis Market, by Product

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Urinalysis, by Product, 2019-2032 (USD Billion)
• 5.3. Consumables
  • 5.3.1. Global Urinalysis Market, by Consumables, by Region, 2019-2032 (USD Billion)
• 5.4. Instrument
  • 5.4.1. Global Urinalysis Market, by Instrument, by Region, 2019-2032 (USD Billion)

6. Global Urinalysis Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Urinalysis Market, by Application, 2019-2032 (USD Billion)
• 6.3. Disease Screening
  • 6.3.1. Global Urinalysis Market, by Disease Screening, by Region, 2019-2032 (USD Billion)
• 6.4. Fertility and Pregnancy Testing
  • 6.4.1. Global Urinalysis Market, by Fertility and Pregnancy Testing, by Region, 2019-2032 (USD Billion)

7. Global Urinalysis Market, by Geography

• 7.1. Key findings
• 7.2. Introduction
  • 7.2.1. Urinalysis Market Assessment, By Geography, 2019-2032 (USD Billion)
• 7.3. Urinalysis Market - North America
  • 7.3.1. North America: Urinalysis Market, by Application, 2019-2032 (USD Billion)
  • 7.3.2. North America: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.3.3. Urinalysis Market - U.S.
    • 7.3.3.1. U.S.: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.3.3.2. U.S.: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.3.4. Urinalysis Market - Canada
    • 7.3.4.1. Canada: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.3.4.2. Canada: Urinalysis Market, by Product, 2019-2032 (USD Billion)
• 7.4. Urinalysis Market - Europe
  • 7.4.1. Europe: Urinalysis Market, by Application, 2019-2032 (USD Billion)
  • 7.4.2. Europe: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.4.3. Urinalysis Market - UK
    • 7.4.3.1. UK: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.4.3.2. UK: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.4.4. Urinalysis Market - France
    • 7.4.4.1. France: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.4.4.2. France: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.4.5. Urinalysis Market - Germany
    • 7.4.5.1. Germany: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.4.5.2. Germany: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.4.6. Urinalysis Market - Italy
    • 7.4.6.1. Italy: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.4.6.2. Italy: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.4.7. Urinalysis Market - Spain
    • 7.4.7.1. Spain: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.4.7.2. Spain: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.4.8. Urinalysis Market - Netherlands
    • 7.4.8.1. Netherlands: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.4.8.2. Netherlands: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.4.9. Urinalysis Market - Russia
    • 7.4.9.1. Russia: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.4.9.2. Russia: Urinalysis Market, by Product, 2019-2032 (USD Billion)
• 7.5. Urinalysis Market - Asia Pacific
  • 7.5.1. Asia Pacific: Urinalysis Market, by Application, 2019-2032 (USD Billion)
  • 7.5.2. Asia Pacific: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.5.3. Urinalysis Market - China
    • 7.5.3.1. China: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.5.3.2. China: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.5.4. Urinalysis Market - India
    • 7.5.4.1. India: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.5.4.2. India: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.5.5. Urinalysis Market - Malaysia
    • 7.5.5.1. Malaysia: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.5.5.2. Malaysia: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.5.6. Urinalysis Market - Japan
    • 7.5.6.1. Japan: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.5.6.2. Japan: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.5.7. Urinalysis Market - Indonesia
    • 7.5.7.1. Indonesia: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.5.7.2. Indonesia: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.5.8. Urinalysis Market - South Korea
    • 7.5.8.1. South Korea: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.5.8.2. South Korea: Urinalysis Market, by Product, 2019-2032 (USD Billion)
• 7.6. Urinalysis Market - Middle East & Africa
  • 7.6.1. Middle East & Africa: Urinalysis Market, by Application, 2019-2032 (USD Billion)
  • 7.6.2. Middle East & Africa: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.6.3. Urinalysis Market - Saudi Arabia
    • 7.6.3.1. Saudi Arabia: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.6.3.2. Saudi Arabia: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.6.4. Urinalysis Market - UAE
    • 7.6.4.1. UAE: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.6.4.2. UAE: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.6.5. Urinalysis Market - Israel
    • 7.6.5.1. Israel: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.6.5.2. Israel: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.6.6. Urinalysis Market - South Africa
    • 7.6.6.1. South Africa: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.6.6.2. South Africa: Urinalysis Market, by Product, 2019-2032 (USD Billion)
• 7.7. Urinalysis Market - Latin America
  • 7.7.1. Latin America: Urinalysis Market, by Application, 2019-2032 (USD Billion)
  • 7.7.2. Latin America: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.7.3. Urinalysis Market - Mexico
    • 7.7.3.1. Mexico: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.7.3.2. Mexico: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.7.4. Urinalysis Market - Brazil
    • 7.7.4.1. Brazil: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.7.4.2. Brazil: Urinalysis Market, by Product, 2019-2032 (USD Billion)
  • 7.7.5. Urinalysis Market - Argentina
    • 7.7.5.1. Argentina: Urinalysis Market, by Application, 2019-2032 (USD Billion)
    • 7.7.5.2. Argentina: Urinalysis Market, by Product, 2019-2032 (USD Billion)

8. Competitive Landscape

• 8.1. Expansion and Acquisition Analysis
  • 8.1.1. Expansion
  • 8.1.2. Acquisitions
• 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

• 9.1. Abbott
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
  • 9.1.4. Recent Development
• 9.2. Sysmex Corporation
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
  • 9.2.4. Recent Development
• 9.3. ACON Laboratories, Inc
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
  • 9.3.4. Recent Development
• 9.4. Bio-Rad Laboratories, Inc
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
  • 9.4.4. Recent Development
• 9.5. ARKRAY Inc
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
  • 9.5.4. Recent Development
• 9.6. F. Hoffmann-La Roche Ltd
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
  • 9.6.4. Recent Development
• 9.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • 9.7.1. Company Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
  • 9.7.4. Recent Development
• 9.8. Siemens Healthcare GmbH
  • 9.8.1. Company Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
  • 9.8.4. Recent Development
• 9.9. Quidel Corporation
  • 9.9.1. Company Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
  • 9.9.4. Recent Development